Abstract
Aim: To analyze clinical, biochemical & treatment profile of patients suffering from CLD secondary to viral hepatitis in our region. Duration & place of study: Descriptive study, January 2021 to July 2021 at Frontier Medical & Dental College, Abbottabad Methods: All patients having chronic liver disease secondary to viral hepatitis with or without complications were enrolled in this study. A diagnosis was made based on clinical findings, biochemical tests, ultrasonography of abdomen and upper GI endoscopy findings. Inclusion criteria further included presence of stigmata suggestive of chronic liver disease and clinical and laboratory parameters which were indicative of portal hypertension. Patients who refused to give consent, pregnant female patients and patients suffering from CLD caused by etiological factors other than hepatitis viruses and who were terminally ill were excluded. Results: Mean age of these patients was 41.25±12.59 years. There were 138 males and only 16 female patients. Majority of the patients, 79.22%, developed anorexia. A large number of patients, 82.47%, had hepatomegaly while 58.44% had firmness in their liver. About 79.87% had splenomegaly, 66.23% had spider naevi, 86.36% had ascites and 87.67% had esophageal varices. Almost half of our patients, 50.65%, used steroid therapy while a large majority of them, 85.06%, were taking antiviral treatment. Mean values of bilirubin, alkaline phosphatase, alanine aminotransferase (ALT), albumin and prothrombin time (PT) were 1.43±1.21 mg/dL, 105.33±51.51 U/L, 85.89±89.65 U/L, 3.82±0.65 g/dL, 62.57±22 seconds respectively. Conclusion: Chronic liver disease secondary to viral hepatitis especially hepatitis B and C virus is quite common in our country. It presents with typical stigmata both clinically and pathologically. There is a need to identify these stigmata and diagnose this condition early to avoid complications in these patients. Keywords: Hepatitis, antiviral, hepatomegaly, liver, bilirubin
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
